Loading…
Tenderkart now works inside Claude and ChatGPT: search and analyse tenders right from your chat
Loading…
Tender ID
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹3.9 LAccepted-Finance ROOM NO 56 3RD FLOOR BLOCK B MEHTA BUILDING B R B BASU ROAD KOLKATA KOLKATA WEST BENGAL 700001 | KOLKATA | WEST BENGAL | 700001 | L1 | Accepted-Finance Fulfills the criteria as per RFP | |
| 2 | L1₹6.5 LAccepted-Finance | L1 | Accepted-Finance Fulfills the criteria as per RFP | |
| 3 | L1₹14.0 LAccepted-Finance ROOM NO 609 6TH FLOOR 32 EZRA STREET LALBAZAR KOLKATA WEST BENGAL 700001 | KOLKATA | WEST BENGAL | 700001 | L1 | Accepted-Finance Fulfills the criteria as per RFP | |
| 4 | L2₹1.7 LAccepted-Finance B 32B KALKAJI NEW DELHI DELHI 110019 | SOUTH EAST DELHI | DELHI | 110019 | L2 | Accepted-Finance Fulfills the criteria as per RFP | |
| 5 | L3₹2.7 LAccepted-Finance WZ 428C NANGAL RAYA NEW DELHI DELHI 110046 | NEW DELHI | DELHI | 110046 | L3 | Accepted-Finance Fulfills the criteria as per RFP |
Tender Value
₹14.7 L
EMD Value
₹44,123
Closing Date
7 Oct 2022, 9:05 amClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
COMDT
CH (EC) KOLKATA
DEPT OF EYE OPD
2022_ARMY_552278_1
RE-D22-470
Open Tender
Miscellaneous Goods
Buy
90 days
DGLP CELL CH (EC) KOLKATA
Please refer Tender documents.
2 documents required · 2 mandatory
₹0
₹44,123
Yes
12 Nov 2022
16 Sept 2022
7 Oct 2022
16 Sept 2022
7 Oct 2022
18 Sept 2022
16 Sept 2022 - 18 Sept 2022
120 days
Drugs
Eye Drop Flurometholone acetate 0.1% w/v bott of 5 ml
E/oint Moxifloxacin 0.5% tube of 5gm
Lotepredenol eTabonate 0.5% bott of 5 ml Eye Drop
E/D Olopatadine + ketorolac 0.4%
E/D Olopatadine hydrochloride 2.2mg sterile with drop tainer dispenser 2.5ml
Inj Sodium Hyaluronate ophthalmic solution prefilled syringe 1%
Inj C3F8 Gas
Methyl Cellulose 2% Solution bott of 5ml
Inj Chondroitin sulphate 40 mg + Sodium hyaluronate 30 mg /ml
Inj Hyaluronidase 1500IU.
Pilocarpine Intracameral Inj 0.5% Pilocarpine nitrate intra-ocular Inj without preservatives, amp of 01ml each
Trypan Blue 0.6% in vial of 1ml Inj
Tropicamide 1% with 5% Phenylephrine eye drops, bott of 5 ml
Pilocarpine Nitrate Eye Solution 2% Bott of 5 ml
Sodium Chloride eye drops 5%, 5 ml bott
Sodium Chloride 6% w/w ointment Tube of 3 gm
E/D Moxifloxacin 5mg/ml, preservative free in drop tainer bottle (with LDP bottle and propylene cap)
E/D Gatifloxacin 0.5% (preservative free)
E/D Moxifloxacin 0.5% with 0.1% Dexamethasone with drop tainer system, 5ml.
E/D Brimonidine Tartarate 0.1 % with CMC eye drops bott of 5 ml
Latanoprost 0.005% with 0.5% Timolol Eye drop bott of 2.5 ml
Latanoprost 0.005 % 2.5ml Eye Drop
Bimatoprost -0.01% W/V with BAK -0.02% , 3ml
E/D Brinzolamide 1%
Dorzolamide 2%, Eye drops
E/D Sodium Carboxy Methyl Cellulose 0.5% with Purite Preservative (Refresh Tears)
Hydroxy propyl methyl cellulose 0.3%, Dextran 70 0.1%, Glycerin 0.2% polyquad 0.001%, with drop-trainer dispensing system, 10ml.
Cyclosporine Emulsion 0.05% with glycerine , castor oil , polysorbate 80, Carbomer 1342, preservative free AA Pack of 30 vial of 0.4 ml each
Inj Mitomycin C 2 mg
Sodium Hyaluronate 1.4% in prefilled syringes, 0.85ml
Inj Interferon Alpha 2b ( Inj (PFS)
Prakash Medicos
VIKASH PHARMACEUTICALS
Tatvam Enterprise
FLORENCE INDIA
Tatvam Enterprise
VIKASH PHARMACEUTICALS
Prakash Medicos
stage.html
html • 0.06 MB
tech_bid_open.pdf
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
fin_eval.pdf
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .